Percutaneous Coronary Intervention

You have accessRestricted access
CULPRIT-SHOCK (Culprit Lesion Only PCI Versus Multivessel Percutaneous Coronary Intervention in Cardiogenic Shock)Implications on Guideline Recommendations
Holger Thiele and Steffen Desch

Circulation. 2018;137:1314-1316, originally published March 26, 2018
https://doi.org/10.1161/CIRCULATIONAHA.117.032907

Download PDF
You have accessRestricted access
Letter by Khan and Boyle Regarding Article, “Early Use of N-Acetylcysteine (NAC) With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Reduces Myocardial Infarct Size (The NACIAM Trial [N-Acetylcysteine in Acute Myocardial Infarction])”
Arshad A. Khan and Andrew J. Boyle

Circulation. 2018;137:1418-1419, originally published March 26, 2018
https://doi.org/10.1161/CIRCULATIONAHA.117.032281

Download PDF
You have accessRestricted access
Letter by Mansour et al Regarding Article, “Early Use of N-Acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Trial [N-Acetylcysteine in Acute Myocardial Infarction])”
Alexandre Mansour, Hervé Le Breton and Vincent Auffret

Circulation. 2018;137:1420-1421, originally published March 26, 2018
https://doi.org/10.1161/CIRCULATIONAHA.117.030180

Download PDF
You have accessRestricted access
Response by Pasupathy et al to Letters Regarding Article, “Early Use of N-acetylcysteine (NAC) With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Reduces Myocardial Infarct Size (The NACIAM Trial [N-Acetylcysteine in Acute Myocardial Infarction])”
Sivabaskari Pasupathy, Rosanna Tavella and John F. Beltrame

Circulation. 2018;137:1424-1425, originally published March 26, 2018
https://doi.org/10.1161/CIRCULATIONAHA.117.032512

Download PDF
You have accessRestricted access
Letter by Ye et al Regarding Article, “Early Use of N-Acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Trial [N-Acetylcysteine in Acute Myocardial Infarction])”
Ziliang Ye, Qiang Su and Lang Li

Circulation. 2018;137:1422-1423, originally published March 26, 2018
https://doi.org/10.1161/CIRCULATIONAHA.117.030312

Download PDF
You have accessRestricted access
Response by Rahman and Perera to Letter Regarding Article, “A Lead to the Culprit”
Haseeb Rahman and Divaka Perera

Circulation. 2018;137:1307-1308, originally published March 19, 2018
https://doi.org/10.1161/CIRCULATIONAHA.117.032342

Download PDF
You have accessRestricted access
Validation of DAPT Score (Dual Antiplatelet Therapy) in East Asian Patients
Hiroto Yabushita and Shinya Goto

Circulation. 2018;137:563-566, originally published February 5, 2018
https://doi.org/10.1161/CIRCULATIONAHA.117.031785

Download PDF
You have accessRestricted access
Randomized Comparisons of Double-Dose Clopidogrel or Adjunctive Cilostazol versus Standard Dual Anti-platelet in Patients with High Post-Treatment Platelet Reactivity: Results of the CREATIVE Trial (Clopidogrel Response Evaluation and AnTi-platelet InterVEntion in High Thrombotic Risk PCI Patients)
Yi-Da Tang, Wenyao Wang, Min Yang, Kuo Zhang, Jing Chen, Shubin Qiao, Hongbing Yan, Yongjian Wu, Xiaohong Huang, Bo Xu, Runlin Gao and Yuejin Yang on behalf of the CREATIVE investigators

Circulation. 2018;CIRCULATIONAHA.117.030190, originally published February 2, 2018
https://doi.org/10.1161/CIRCULATIONAHA.117.030190

Download PDF
You have accessRestricted access
Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve–Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery DiseaseThree-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation)
William F. Fearon, Takeshi Nishi, Bernard De Bruyne, Derek B. Boothroyd, Emanuele Barbato, Pim Tonino, Peter Jüni, Nico H.J. Pijls and Mark A. Hlatky for the FAME 2 Trial Investigators

Circulation. 2018;137:480-487, originally published November 2, 2017
https://doi.org/10.1161/CIRCULATIONAHA.117.031907

Download PDF
You have accessRestricted access
Three-Year Outcomes With the Absorb Bioresorbable ScaffoldIndividual-Patient-Data Meta-Analysis From the ABSORB Randomized Trials
Ziad A. Ali, Runlin Gao, Takeshi Kimura, Yoshinobu Onuma, Dean J. Kereiakes, Stephen G. Ellis, Bernard Chevalier, Minh-thien Vu, Zhen Zhang, Charles A. Simonton, Patrick W. Serruys and Gregg W. Stone

Circulation. 2018;137:464-479, originally published October 31, 2017
https://doi.org/10.1161/CIRCULATIONAHA.117.031843

Download PDF

Header Publisher Menu

Circulation

Percutaneous Coronary Intervention

Pages

Current Issue

Search This Journal

Related Collections

Customer Service

About Us

Our Sites

Take Action

Online Communities